Inventor
Daniel W. Norbeck
Inventor
Crystal Lake, IL, US
Overview
Patents· 69 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds25%
C07CAcyclic or carbocyclic compounds19%
A61KPreparations for medical, dental or toiletry purposes18%
C07KPeptides16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07BGeneral methods of organic chemistry2%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C40BCombinatorial chemistry1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
7,968,707'Retroviral protease inhibiting compounds'20117,279,582'Retroviral protease inhibiting compounds'20076,703,403'Method for improving pharmacokinetics'20046,667,404'Retroviral protease inhibiting compounds'20036,531,610'Retroviral protease inhibiting compounds'20036,472,529'Retroviral protease inhibiting compounds'20026,355,490'Attached tags for use in combinatorial chemistry synthesis'20026,313,296'Retroviral protease inhibiting compounds'20016,297,021'Ligand screening and design by X-ray crystallography'20016,284,767'Retroviral protease inhibiting compounds'20016,274,385'Attached tags for use in combinatorial chemistry synthesis'20016,251,906'Retroviral protease inhibiting compounds'20016,168,913'Coding combinatorial libraries with fluorine tags'20016,150,530'Retroviral protease inhibiting compounds'20006,037,157'Method for improving pharmacokinetics'20006,017,928'Retroviral protease inhibiting compounds'20005,990,135'Retroviral protease inhibiting compounds'19995,914,332'Retroviral protease inhibiting compounds'19995,905,068'Retroviral protease inhibiting compounds'19995,892,052'Process for making retroviral protease inhibiting compounds'19995,886,036'Retroviral protease inhibiting compounds'19995,846,987'Retroviral protease inhibiting compounds'19985,837,873'Intermediates of retroviral protease inhibiting compounds'19985,696,270'Intermediate for making retroviral protease inhibiting compounds'19975,679,797'Retroviral protease inhibiting compounds'19975,674,882'Retroviral protease inhibiting compounds'19975,670,675'Retroviral protease inhibiting compounds'19975,659,044'Retroviral protease inhibiting compounds'19975,659,045'Retroviral protease inhibiting compounds'19975,648,497'Retroviral protease inhibiting compounds'19975,635,523'Retroviral protease inhibiting compounds'19975,631,376'Retroviral protease inhibiting compounds'19975,625,072'Retroviral protease inhibiting compounds'19975,625,092'Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane'19975,621,109'Retroviral protease inhibiting compounds'19975,616,720'Retroviral protease inhibiting compounds'19975,616,714'Retroviral protease inhibiting compounds'19975,608,072'Retroviral protease inhibiting compounds'19975,597,927'Retroviral protease inhibiting compounds'19975,597,926'Retroviral protease inhibiting compounds'19975,597,824'Analogs of oxetanyl purines and pyrimidines'19975,597,928'Retroviral protease inhibiting compounds'19975,591,860'Retroviral protease inhibiting compounds'19975,583,232'Retroviral protease inhibiting compounds'19965,583,233'Retroviral protease inhibiting compounds'19965,580,984'Retroviral protease inhibiting compounds'19965,565,418'Retroviral protease inhibiting compounds'19965,554,783'Retroviral protease inhibiting compounds'19965,552,558'Retroviral protease inhibiting compounds'19965,545,750'Retroviral protease inhibiting compounds'19965,543,551'Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane'19965,541,328'Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane'19965,541,206'Retroviral protease inhibiting compounds'19965,541,321'Process for the preparation of a substituted diaminoalcohol'19965,541,320'Process for the preparation of a substituted diaminoalcohol'19965,541,334'Retroviral protease inhibiting compounds'19965,539,122'Retroviral protease inhibiting compounds'19965,491,253'Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane'19965,461,067'Retroviral protease inhibiting compounds'19955,455,351'Retroviral protease inhibiting piperazine compounds'19955,436,339'Process for the preparation of a substituted diaminoalcohol'19955,420,276'Analogs of oxetanyl purines and pyrimidines'19955,354,866'Retroviral protease inhibiting compounds'19945,256,677'Retroviral protease inhibiting compounds'19935,246,931'Carbocyclic nucleoside analogs'19935,153,352'Process for preparation of intermediates of carbocyclic nucleoside analogs'19925,151,438'Retroviral protease inhibiting compounds'19925,142,056'Retroviral protease inhibiting compounds'19924,988,703'Carbocyclic nucleoside analogs with antiviral activity'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–2011Patents assigned to ABBOTT LAB (64)· patent assignee history
1991–1998Based in Lindenhurst, IL, US· patent location history
1992–1993Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
1995–2011Based in Crystal Lake, IL, US· patent location history
1997Patents assigned to ABBOTT LABORAOTRIES (1)· patent assignee history
1999Patents assigned to ABBOTT LABORTORIES (1)· patent assignee history
2001Based in Grayslake, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 64 | 1991–2011 |
| BRISTOL MYERS SQUIBB CO | 2 | 1992–1993 |
| ABBOTT LABORAOTRIES | 1 | 1997 |
| ABBOTT LABORTORIES | 1 | 1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Crystal Lake, Illinois, US | 49 | 1995–2011 |
| Lindenhurst, Illinois, US | 17 | 1991–1998 |
| Grayslake, Illinois, US | 3 | 2001 |